Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Cureus|September 11, 2019
Extensive Unpredictable Pancreas Cancer Inter-fraction Motion: A Case ReportSangjune L Lee, Michael Velec, Pablo Munoz-Schuffenegger, et al.
International Journal of Radiation Oncology, Biology, Physics|January 3, 2012
Accumulated dose in liver stereotactic body radiotherapy: positioning, breathing, and deformation effectsMichael Velec, Joanne L Moseley, Tim Craig, et al.
Journal of Applied Clinical Medical Physics|January 15, 2021
MRI evaluation of normal tissue deformation and breathing motion under an abdominal compression deviceMaureen Lee, Anna Simeonov, Teo Stanescu, et al.
International Journal of Radiation Oncology, Biology, Physics|April 4, 2019
Redefining Ventricular Target Volume in Germinoma: Is Inclusion of Temporal Horns Necessary?Michael Yan, Normand Laperriere, Michael Velec, et al.
Acta Oncologica (Stockholm, Sweden)|November 10, 2020
Simulated daily plan adaptation for magnetic resonance-guided liver stereotactic body radiotherapyEdward Taylor, Jelena Lukovic, Michael Velec, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 4, 2025
Survey of radiation therapists' current practices and perceptions of psychosocial and supportive care in Canada and NorwaySophie Bezanson, Espen Aas, Kerry-Ann Smith, et al.
Medical Physics|February 11, 2012
A novel technique to enable experimental validation of deformable dose accumulationCarolyn J Niu, Warren D Foltz, Michael Velec, et al.
Advances in Radiation Oncology|October 30, 2018
A simulation study to assess the potential impact of developing normal tissue complication probability models with accumulated doseMolly M McCulloch, Daniel G Muenz, Matthew J Schipper, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 1, 2023
Liver SBRT dose accumulation to assess the impact of anatomic variations on normal tissue doses and toxicity in patients treated with concurrent sorafenibJasmine Chen, Jean-Pierre Bissonnette, Tim Craig, et al.
Pageof 4